MedPath
NMPA Approval

Tildrakizumab Injection

国药准字SJ20230006

May 26, 2023

Drug Information

替瑞奇珠单抗注射液

益路取

注射剂

100mg(1 ml)/支

生物制品

May 26, 2023

May 25, 2028

Company Information

Applicant Company

Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai, Maharashtra, 400063, INDIA

Manufacturing Company

Vetter Pharma-Fertigung, Schutzenstr. 87 und 99-101, Ravensburg 88212 GERMANY

© Copyright 2025. All Rights Reserved by MedPath
替瑞奇珠单抗注射液 - NMPA 批准文号 | MedPath